A new gene therapy can reverse the effects of heart failure and restore heart function in a large animal model.
Japanese Kyowa Kirin acquires Orchard to bolster gene therapy pipeline – Pharmaceutical Technology
Kyowa will pay $16.00 per American Depositary Share (ADS) in cash for Orchard, totalling about ¥57.3bn ($387.4m). Image Credit: vchal / Shutterstock. The Japan-based pharmaceutical